Article info

Download PDFPDF
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

Authors

  1. Correspondence to Professor Matteo Brunelli, Department of Diagnostics and Public Health, Pathology Unit, University and Hospital Trust of Verona, 37134 Verona, Italy; matteo.brunelli{at}univr.it
View Full Text

Citation

Brunelli M, Tafuri A, Cima L, et al
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

Publication history

  • Received September 5, 2020
  • Revised October 13, 2020
  • Accepted October 15, 2020
  • First published November 3, 2020.
Online issue publication 
December 15, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.